Universe Pharmaceuticals INC
UPC
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.97M
Close$
$-3.45
203.7% downside
Current Fair Value
203.7% downsideOvervalued by 203.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.97 Million |
|---|---|
| Enterprise Value | $-21,681,935.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1055.75 |
| Beta | 1.58 |
| Outstanding Shares | 563,338 |
Return
| Return on Equity | -22.09% |
|---|---|
| Return on Assets | -17.89% |
| Return on Invested Capital | -20.10% |
Valuation & Multiples
| P/E Ratio | -0.54 |
|---|---|
| PEG | 0.49 |
| Price to Sales | 0.05 |
| Price to Book Ratio | 0.03 |
| Enterprise Value to Revenue | -0.53 |
| Enterprise Value to EBIT | 1.92 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | -0.46 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
April 22, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 27.20%▲ 27.20% |
|---|---|
| Total Invested | $3,604 |
| Investors Holding | 1▲ 1.00% |
ESG Score
No data
About Universe Pharmaceuticals INC
Universe Pharmaceuticals INC, headquartered in Ji’an, Jiangxi, China, is a pharmaceutical producer and distributor in China. The Company specializes in the manufacturing, marketing, sales and distribution of traditional Chinese medicine ...